Literature DB >> 20100563

Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in Chinese Han populations from four different geographic areas of Mainland China.

Kefu Tang1, Xin Li, Qinghe Xing, Weidong Li, Guoyin Feng, Lin He, Shengying Qin.   

Abstract

CYP2E1 is one of a superfamily of enzymes that play a central role in activating and detoxifying many xenobiotics and endogenous compounds thought to be involved in the development of several human diseases. Among other factors, individual susceptibility to developing these pathologies relies on genetic polymorphisms, which are related to ethnic differences, since the frequency of mutant genotypes varies in different populations. The aim of this study was to investigate the genetic basis of CYP2E1 polymorphisms in the populations of four different geographical locations of China. Twenty-two different CYP2E1 polymorphisms, including six novel variants in promoter regions and a novel nonsense mutation, were identified. The frequencies of some polymorphisms and genotypes demonstrated significant differences among the four populations. Linkage disequilibrium analysis and tag SNP selection were performed. Haplotypes were analyzed within the selected tag SNPs. Tag SNP selection and haplotype distributions showed differences across the four populations. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100563     DOI: 10.1016/j.ygeno.2010.01.005

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  13 in total

1.  Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population.

Authors:  J Jiang; X Zhang; R Huo; X Li; Y Yang; Z Gai; M Xu; L Shen; L Cai; C Wan; B Li; L He; S Qin
Journal:  Pharmacogenomics J       Date:  2014-12-02       Impact factor: 3.550

2.  Functional characterization of the chlorzoxazone 6-hydroxylation activity of human cytochrome P450 2E1 allelic variants in Han Chinese.

Authors:  Ting Wang; Huihui Du; Jingsong Ma; Lu Shen; Muyun Wei; Xianglong Zhao; Luan Chen; Mo Li; Guorong Li; Qinghe Xing; Lin He; Shengying Qin
Journal:  PeerJ       Date:  2020-07-31       Impact factor: 2.984

3.  Association study between FSHR Ala307Thr and Ser680Asn variants and polycystic ovary syndrome (PCOS) in Northern Chinese Han women.

Authors:  Lingyuan Fu; Zhaofeng Zhang; Aiping Zhang; Jianhua Xu; Xianliang Huang; Qiupeng Zheng; Yunlei Cao; Lei Wang; Jing Du
Journal:  J Assist Reprod Genet       Date:  2013-03-29       Impact factor: 3.412

4.  Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.

Authors:  Ran Huo; Kefu Tang; Zhiyun Wei; Lu Shen; Yuyu Xiong; Xi Wu; Jiamin Niu; Xia Han; Zhengan Tian; Lun Yang; Guoyin Feng; Lin He; Shengying Qin
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

5.  Systematic functional characterization of cytochrome P450 2E1 promoter variants in the Chinese Han population.

Authors:  Xunyi Huang; Lili Chen; Wenlong Song; Ling Chen; Jiamin Niu; Xia Han; Guoyin Feng; Lin He; Shengying Qin
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

Review 6.  Improved drug therapy: triangulating phenomics with genomics and metabolomics.

Authors:  Andrew A Monte; Chad Brocker; Daniel W Nebert; Frank J Gonzalez; David C Thompson; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2014-09-01       Impact factor: 4.639

7.  Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients.

Authors:  Y Shi; M Li; C Song; Q Xu; R Huo; L Shen; Q Xing; D Cui; W Li; J Zhao; L He; S Qin
Journal:  Transl Psychiatry       Date:  2017-07-11       Impact factor: 6.222

8.  Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.

Authors:  Yu Cai; JiaYong Yi; ChaoHui Zhou; XiZhong Shen
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

9.  A systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland China--a basis for personalized therapy.

Authors:  Zhenqiang Wu; Xiaoqing Zhang; Lu Shen; Yuyu Xiong; Xi Wu; Ran Huo; Zhiyun Wei; Lei Cai; Guoyang Qi; Qingqing Xu; Daxiang Cui; Donghong Cui; Gengchun Zhao; Lin He; Shengying Qin
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

10.  Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in a Chinese Tibetan population.

Authors:  Li Wang; Guoxia Ren; Jingjie Li; Linhao Zhu; Fanglin Niu; Mengdan Yan; Jing Li; Dongya Yuan; Tianbo Jin
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.